Osteopathic medical degree
- University of Health Sciences, Kansas City, MO
Internship / Residency
- Internal Medicine - Naval Regional Medical Center, San Diego
- Pulmonary Disease & Internal Medicine - American Board of Internal Medicine
- Fellow, American College of Chest Physicians
- Fellow, American College of Physicians
- Pulmonary Medicine - Naval Regional Medical Center
Dr. Daniel Nader leads the interventional pulmonology program at Cancer Treatment Centers of America® (CTCA), Tulsa. Thanks to his vision and determination, CTCA® is able to offer patients the latest advances in the diagnosis and treatment of lung cancer.
Dr. Nader, who has been with CTCA since 1991, has been recognized by Castle Connolly, U.S. News & World Report and Oklahoma magazine as a top doctor in pulmonary medicine.
Dr. Nader earned an osteopathic medical degree from the University of Health Sciences in Kansas City, Missouri. He completed an internal medicine residency and a pulmonary medicine fellowship at the Naval Regional Medical Center in San Diego, California. He is board certified in internal medicine and pulmonary disease.
Previously, Dr. Nader was Medical Director of a pulmonary function lab and respiratory therapy department. Today, he serves as Director of the lung program and Chief of Staff at CTCA in Tulsa.
Dr. Nader has served as the Oklahoma Governor of the American College of Chest Physicians (ACCP). He was one of about 55 ACCP Governors throughout the United States and Canada. The role allowed him to act as a patient advocate, making contact with local government officials to help lobby for Oklahoma issues and concerns. He also served as an important link between the cardiopulmonary community in Oklahoma and the national body.
Dr. Nader says he is grateful to CTCA for the opportunity to use a broad range of advanced technologies to make a real difference in the lives of patients.
Patient ratings and comments
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.